Type of Cancer
Genito-Urinary
Phase
Division (Location)
Study ID
NCT#
Brief Description
A Randomized, Double-Blinded, Phase II Study of Maintenance Pembrolizumab versus Placebo after First-line Chemotherapy in Patients with Metastatic Urothelial Cancer
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.